The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
NCT03857646
Female Urogenital Diseases and Pregnancy Complications, Hyperphagia
Houston, Texas, United States
View Trial DetailsNCT Number: NCT00865150
Primary Hypotheses of the study include:
* Metabolic profiles are influenced by gestational age, chronological age, type and degree of nutritional support and illness * Metabolic profiles differ between neonates who receive commercial formula and neonates who receive primarily human breast milk * Neonates who develop parenteral associated cholestasis have metabolic markers that identify at risk patients (high serum urea nitrogen, citrulline, histidine, methionine, and succinyl carnitine and low thyroxine, serine and glutamate) * Neonates that have hypothyroidism have abnormal metabolic profiles (low tyrosine levels)
Looking for future studies?
Notify Me23 week–31 week
All sexes
Observational
Memorial Hospital South Bend, South Bend, Indiana, United States
Malnutrition is a common problem in the neonatal intensive care unit. Recent studies indicate that prematurely born neonates commonly develop a severe nutritional deficit during the first weeks after birth, referred to as extrauterine growth restriction. Despite an increase in growth during the second month of hospitalization, many neonates are ultimately discharged home having grown inadequately. The early nutritional deficit affects weight gain as well as growth in length and head circumference. Aggressive administration of parenteral amino acids to improve protein accretion rates in very preterm neonates has been supported in the literature. Although tolerance of high dose amino acids has been described, researchers acknowledge that sensitive tests to monitor amino acid toxicity are not readily available in the clinical setting.
The goals of this study are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 42 Days of Life
Time frame: 42 Days of Life
Pediatrix
Other
How Illness and Nutritional Support Influence Amino Acid and Acylcarnitine Profiles in Premature Neonates
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03857646
Female Urogenital Diseases and Pregnancy Complications, Hyperphagia
Houston, Texas, United States
View Trial DetailsNCT03767634
Death, Female Urogenital Diseases and Pregnancy Complications
London, United Kingdom
View Trial DetailsNCT07689669
Apnea, Apnea of Prematurity
Konya, Turkey (Türkiye)
View Trial DetailsNCT07622459
Female Urogenital Diseases and Pregnancy Complications, Mechanical Ventilation
Sanliurfa, Turkey (Türkiye)
View Trial Details